Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
Journal article published in 2021 by
Christopher J. Day,
Benjamin Bailly 
,
Patrice Guillon,
Larissa Dirr,
Freda E.-C. Jen,
Belinda L. Spillings,
Johnson Mak,
Mark von Itzstein,
Thomas Haselhorst,
Michael P. Jennings
,
Patrice Guillon,
Larissa Dirr,
Freda E.-C. Jen,
Belinda L. Spillings,
Johnson Mak,
Mark von Itzstein,
Thomas Haselhorst,
Michael P. Jennings
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
SARS-CoV-2, the causative agent of COVID-19, has caused more than 60 million cases worldwide with almost 1.5 million deaths as of November 2020. Repurposing existing drugs is the most rapid path to clinical intervention for emerging diseases.